Mitsubishi Tanabe Pharma Corporation

• Changes in Abdominal Adiposity and Associations With Metabolic Health Markers Following Tirzepatide in Japanese Participants With Obesity Disease: Results From the SURMOUNT-J Study

  19 Sept 2026

Sources: api.crossref.org

• Distinct metabolomic signatures of SGLT2 inhibitor vs. sulfonylurea in a paired human liver biopsy study

  Consulting or advice, Fees or honoraria, Grants or research support, 14 Sept 2026

• Fall risk in rheumatoid arthritis revisited: A follow-up study focusing on sarcopenia and glucocorticoid use

  Fees or honoraria, 8 Sept 2026

• Long-term safety of oral orforglipron in Japanese participants with type 2 diabetes (ACHIEVE-J): a multicentre, randomised, open-label, parallel-group phase 3 trial

  Fees or honoraria, 17 Aug 2026

• Associations of Hearing Loss Defined by Updated World Health Organization Criteria With Socioeconomic Status and Health Check-Up-Related Factors: A Population-Based Cross-Sectional Study in Japan

  Fees or honoraria, 1 Aug 2026

• Prognostic Impact of Combined Nutritional and Cognitive Status on Long-Term Outcome in Acute Decompensated Heart Failure

  Fees or honoraria, Grants or research support, 6 Jan 2026

• Towards a reference cell atlas of liver diversity over the human lifespan

  Consulting or advice, 13 Oct 2025

• Healthy aging and aging-related kidney diseases: lessons from centenarians

  Grants or research support, 12 Sept 2025

• Efficacy and safety of a novel dual GIP and GLP-1 receptor agonist tirzepatide in patients with type 2 diabetes (SURPASS-1): a double-blind, randomised, phase 3 trial

  Fees or honoraria, 27 Jun 2021

Sources: pubmed.ncbi.nlm.nih.gov

• Effect of Luseogliflozin on Myocardial Flow Reserve in Patients with Type 2 Diabetes Mellitus (LUCENT-J Study)

  ADA Scientific Sessions 2026 abstract, 6 Jun 2026

• Enhanced Renal Protective Effects of Tirzepatide in T2D People

  ADA Scientific Sessions 2025 abstract, 13 Jun 2025

• Five-Year Changes in Glucose Tolerance, Insulin Secretion, and Insulin Resistance in Community-Dwelling Older Adults

  ADA Scientific Sessions 2025 abstract, 13 Jun 2025